228 related articles for article (PubMed ID: 12923822)
1. Comparison of three antipsychotics in the emergency psychiatric setting.
Raja M; Azzoni A
Hum Psychopharmacol; 2003 Aug; 18(6):447-52. PubMed ID: 12923822
[TBL] [Abstract][Full Text] [Related]
2. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
[TBL] [Abstract][Full Text] [Related]
3. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.
Bobes J; Garc A-Portilla MP; Rejas J; Hern Ndez G; Garcia-Garcia M; Rico-Villademoros F; Porras A
J Sex Marital Ther; 2003; 29(2):125-47. PubMed ID: 12623765
[TBL] [Abstract][Full Text] [Related]
4. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA
Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
[TBL] [Abstract][Full Text] [Related]
6. Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study.
Voruganti L; Cortese L; Owyeumi L; Kotteda V; Cernovsky Z; Zirul S; Awad A
Schizophr Res; 2002 Oct; 57(2-3):201-8. PubMed ID: 12223251
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.
McEvoy JP; Lieberman JA; Perkins DO; Hamer RM; Gu H; Lazarus A; Sweitzer D; Olexy C; Weiden P; Strakowski SD
Am J Psychiatry; 2007 Jul; 164(7):1050-60. PubMed ID: 17606657
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone.
Johnsen E; Kroken RA; Wentzel-Larsen T; Jørgensen HA
BMC Psychiatry; 2010 Mar; 10():26. PubMed ID: 20334680
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: a retrospective study.
Pae CU; Nassir Ghaemi S; Patkar A; Chae JH; Bahk WM; Jun TY; Masand P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1322-5. PubMed ID: 16631294
[TBL] [Abstract][Full Text] [Related]
10. Comparison of risperidone and olanzapine as used under "real-world" conditions in a state psychiatric hospital.
Advokat C; Dixon D; Schneider J; Comaty JE
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):487-95. PubMed ID: 15093956
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, randomized trial.
Johnsen E; Jørgensen HA; Kroken RA; Løberg EM
Eur Psychiatry; 2013 Mar; 28(3):174-84. PubMed ID: 22153730
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial.
Kilian R; Steinert T; Schepp W; Weiser P; Jaeger S; Pfiffner C; Frasch K; Eschweiler GW; Messer T; Croissant D; Becker T; Längle G
Eur Arch Psychiatry Clin Neurosci; 2012 Oct; 262(7):589-98. PubMed ID: 22526729
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
[TBL] [Abstract][Full Text] [Related]
14. Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study.
Johnsen E; Sinkeviciute I; Løberg EM; Kroken RA; Hugdahl K; Jørgensen HA
BMC Psychiatry; 2013 Sep; 13():241. PubMed ID: 24079855
[TBL] [Abstract][Full Text] [Related]
15. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
Sacchetti E; Valsecchi P; Parrinello G;
Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497
[TBL] [Abstract][Full Text] [Related]
16. [New antipsychotic drugs].
Weizer M; Levy A; Davidson M
Harefuah; 1997 Jul; 133(1-2):57-60. PubMed ID: 9332062
[No Abstract] [Full Text] [Related]
17. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic polypharmacy, Part 1: Therapeutic option or dirty little secret?
Stahl SM
J Clin Psychiatry; 1999 Jul; 60(7):425-6. PubMed ID: 10453794
[TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
Conley RR; Mahmoud R
Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
[TBL] [Abstract][Full Text] [Related]
20. Use of atypical antipsychotics in mood disorders.
Weizman R; Weizman A
Curr Opin Investig Drugs; 2001 Jul; 2(7):940-5. PubMed ID: 11757795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
